GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Deferred Tax

HTDS (Hard to Treat Diseases) Deferred Tax : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Hard to Treat Diseases's change in deferred tax for the three months ended in . 20 was $0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Hard to Treat Diseases Deferred Tax Historical Data

The historical data trend for Hard to Treat Diseases's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Deferred Tax Chart

Hard to Treat Diseases Annual Data
Trend
Deferred Tax

Hard to Treat Diseases Quarterly Data
Deferred Tax

Hard to Treat Diseases Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hard to Treat Diseases Deferred Tax Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Deferred Tax
Comparable Companies
PSID GBSN ETAH IMEXF OXIS ABMC ATOS MEDD BTHCF MTST DIGP ROSG IDYLF BZYR TBIOD TEAR GNWSF LEDIF ROKA GENE
Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Website
http://www.htdsmedical.com
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases Headlines

No Headlines